Details

NameSymbolSector
GLENMARK PHARMACEUTICALS LTDGLENMARKPharmaceuticals
Open
2250.5
High
2266.9
Low
2223.7
Close
2226.7
Volume
695427
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Glenmark Pharmaceuticals is  
None
Estimated Stoploss of Glenmark Pharmaceuticals is ₹  
2266.9
Glenmark Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Glenmark Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Glenmark Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Glenmark Pharmaceuticals is  
Downℹ
 by  

4.31

%. 
Target
Buy @ 

2129.61

Sell @ 

2485.87

Current @ 

2226.7

Volume

Glenmark Pharmaceuticals has seen  
Moderateℹ
 volume of trades. 
The volume trend for Glenmark Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Glenmark Pharmaceuticals is  

Up

 by  

24.77

% 

Valuation

The current market price of Glenmark Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 16049cr and total assets worth ₹ 16049cr, the balance sheet of Glenmark Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Glenmark Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Downℹ
 by  

92.09

%. 

(*Mar 2025)

49.49% i.e. ₹ 827cr spent in operatingℹ
0.12% i.e. ₹ 2cr earned in investingℹ
47.1% i.e. ₹ 787cr earned in financingℹ
3.29% i.e. ₹ 55cr earned in otherℹ
Glenmark Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 215cr

. It is  
Upℹ
 by  

571.88

%. 

(*Mar 2024)

2.98% i.e. ₹ 265cr spent in operatingℹ
51.21% i.e. ₹ 4560cr earned in investingℹ
43.86% i.e. ₹ 3906cr spent in financingℹ
1.95% i.e. ₹ 174cr spent in otherℹ
Income
The income of Glenmark Pharmaceuticals is  

₹ 6247cr

 and  

Profit

 is :  

₹ 610cr

(*Sep 2025)

Glenmark Pharmaceuticals Profit is up by:  

1226.09

% and Income is Up by:  

89.88

% 

(*Sep 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3290cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Glenmark Pharmaceuticals Profit is up by:  

1050

% and Income is Up by:  

0.7

% 

(*Jun 2025)

The income of Glenmark Pharmaceuticals is  

₹ 3267cr

 and  

Profit

 is :  

₹ 4cr

(*Mar 2025)

Glenmark Pharmaceuticals Profit is down by:  

98.85

% and Income is Down by:  

4.42

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.